You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Nicholas M. Dean

Executive Officer at Providence Therapeutics, Inc.
Overview
Relationships
Paths
Education
Career History
Boards & Committees
Investments
Transactions

Nicholas M. Dean

Executive Officer at Providence Therapeutics, Inc.

Overview

Age
60 (Born 1958)
Notable Companies
Ionis Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc.
Board Seats
4
Number of Relationships
This person is connected to 145 people.

Relationships See Details


Senior Vice President, Manufacturing & Supply Chain at Boston Scientific Corporation

Executive Chairman at Redwood Bioscience, Inc.

R&D & Medical Consultant at Arcturus Therapeutics, Inc.

Founder, Chief Executive Officer & Chairman of the Board of Directors at Dermira, Inc.

Professor, Medicine at University of Pennsylvania - Perelman School of Medicine

Chief Financial Officer & Secretary at biOasis Technologies, Inc.

Managing Director at RiverVest Venture Management LLC

Executive Chairman, Chief Executive Officer & Chief Financial Officer at Sydys Corp.

Executive Officer at Providence Therapeutics, Inc.

Managing Director at RiverVest Venture Management LLC
See 135 more listings with RelSci Professional.

Paths to Nicholas M. Dean

Nicholas M. Dean
You
Connections via Relationship Science
Nicholas M. Dean
Sync your contacts to see how you can connect with Nicholas M. Dean.

Educational Background

Doctorate 
ght into being through the determination, enthusiasm for learning, and generosity of ordinary Welsh people, the establishment of the University of Wales by Royal Charter in 1893 was regarded as one of the most important political and social developments in the nineteenth century. The University of Wales has a long and proud history, playing an important role in the development of higher education in Wales. Through the University’s support for the Centre for Advanced Welsh and Celtic Studies (CAWCS), Geiriadur Prifysgol Cymru (The Welsh Dictionary), Gregynog Hall (bequeathed to the University in the 1960’s) and the University of Wales Press, it helped to promote and celebrate the language, heritage and culture of Wales.
Ph.D. in Pharmacology 

Career History

Executive Officer
Current
Founder
2006 - 2012
Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.
Executive Director & Vice President, Functional Genomics & Oncology
1991 - Prior
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates its business through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke on January 10, 1989 and is headquartered in Carlsbad, CA.
Director & Chief Scientific Officer
Prior
Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY.

Boards & Committees

Corporate Boards ▾
Director
Current
Member, Scientific Advisory Board
Prior - 2015
Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA.
Director & Chief Scientific Officer
2006 - 2012
Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.
Director & Chief Scientific Officer
Prior
Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY.

Investments

Details Hidden
Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.

Transactions

Details Hidden
Providence Therapeutics, Inc. raised money in a private placement transaction

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.